From a clinical study standpoint, the progress of novel therapies requires a rigorous and comprehensive approach. We are witnessing a pivotal shift from traditional models, embracing tailored medicine and increasingly complex methodologies. Cutting-edge biomarker discovery, coupled with advanced imaging techniques, is allowing for a far more precis